Interaction of CYP3A4, CYP3A5, CYP1A1 and CYP2B6 genes in the development of organotoxic effects of chemotherapy in patients with Hodgkin's lymphoma

This publication has 24 references indexed in Scilit:

• Human Family 1–4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update
  Archives of Toxicology, 2021
• Cytochrome P4501B1 in bone marrow is co-expressed with key markers of mesenchymal stem cells. BMS2 cell line models PAH disruption of bone marrow niche development functions
  Toxicology and Applied Pharmacology, 2020
• Hodgkin lymphoma: A 2020 update on diagnosis, risk‐stratification, and management
  American Journal of Hematology, 2020
• Drug-Disease Interaction: Effect of Inflammation and Nonsteroidal Anti-Inflammatory Drugs on Cytochrome P450 Metabolites of Arachidonic Acid
  Journal of Pharmaceutical Sciences, 2018
• Cytochrome P450 Genetic Variations Can Predict mRNA Expression, Cyclophosphamide 4-Hydroxylation, and Treatment Outcomes in Chinese Patients With Non-Hodgkin's Lymphoma
  The Journal of Clinical Pharmacology, 2017
• Significant role of CYP450 genetic variants in cyclophosphamide based breast cancer treatment outcomes: a multi-analytical strategy
  Clinica Chimica Acta, 2014
• Cytochrome P450 enzymes and the heart
  IUBMB Life, 2009
• Induction of several cytochrome P450 genes by doxorubicin in H9c2 cells
  Vascular Pharmacology, 2008
• The effect of flavonoid derivatives on doxorubicin transport and metabolism
  Bioorganic & Medicinal Chemistry, 2008
• Inhibitory effects of anticancer drugs on dextromethorphan-O-demethylase activity in human liver microsomes
  Cancer Chemotherapy and Pharmacology, 1993